Related Experiment Video
Updated: May 11, 2025

A Familial Hypercholesterolemia Human Liver Chimeric Mouse Model Using Induced Pluripotent Stem Cell-derived Hepatocytes
Published on: September 15, 2018
LDL cholesterol burden in elderly patients with familial hypercholesterolemia: Insights from real-world data
Torunn Melnes1, Martin P Bogsrud2,3, Jacob J Christensen1
1Department of Nutrition, Institute of Basic Medical Sciences, University of Oslo, Oslo, Norway.
Insights
Familial hypercholesterolemia (FH) patients with coronary heart disease (CHD) had a higher LDL-C burden, especially before treatment. This highlights the critical need for early detection and intervention in FH to prevent cardiovascular events.
Area of Science:
- Cardiology
- Genetics
- Metabolic Disorders
Background:
- Familial hypercholesterolemia (FH) is a genetic disorder causing high LDL-C and premature coronary heart disease (CHD).
- Cumulative LDL-C exposure (LDL-C burden) may be a better cardiovascular risk predictor than current LDL-C levels in FH.
- Real-world data is crucial for understanding LDL-C burden in elderly FH patients.
Purpose of the Study:
- To estimate LDL-C burden at various ages in elderly FH patients with and without CHD.
- To assess the LDL-C burden at the time of CHD onset in FH patients.
- To compare LDL-C burden between FH patients with and without CHD.
Main Methods:
- Retrospective data collection from elderly FH patients (>60 years) at a Lipid Clinic.
- Calculation of LDL-C burden (mM-years) using repeated LDL-C measurements and medication data.
- Estimation of time-weighted average (TWA) LDL-C by dividing LDL-C burden by duration.
Main Results:
- FH patients with CHD had a significantly higher LDL-C burden at ages 45, 50, and 60 compared to those without CHD.
- Higher TWA LDL-C was observed before treatment initiation in the CHD group, but not during follow-up.
- No significant sex differences in LDL-C burden were found, though women had higher TWA LDL-C during follow-up.
Conclusions:
- Elderly FH patients with CHD exhibit a higher LDL-C burden, primarily due to elevated levels before treatment.
- These findings underscore the importance of early diagnosis and aggressive lipid-lowering therapy in FH to mitigate cardiovascular risk.
- The study emphasizes LDL-C burden as a key metric for assessing long-term cardiovascular risk in FH.
Background And Aims:
Familial hypercholesterolemia (FH) is a genetic disorder characterized by elevated low-density lipoprotein cholesterol (LDL-C) and increased risk of premature coronary heart disease (CHD). While current LDL-C levels usually guides therapy, the cumulative exposure to LDL-C (the LDL-C burden) is suggested to offer a more precise estimate of cardiovascular risk in people with FH. Therefore, using real-world data, this study aimed to estimate the LDL-C burden at different ages in elderly FH patients with and without CHD, and to assess the LDL-C burden at CHD onset.
Methods:
Data was retrospectively collected from the medical records of elderly (>60 years) FH patients at the Lipid Clinic in Oslo. The LDL-C burden (mM-years) was estimated based on repeated LDL-C measurements and information on lipid-lowering medication. Time-weighted average (TWA) LDL-C was calculated as LDL-C burden divided by years.
Results:
We included 112 FH patients, of which 55 (49 %) had experienced at least one CHD-event, and 58 (52 %) were females. Median age at first and last visit were 50 years and 68 years, respectively, with a median of 9 (range; 2-14) available LDL-C measurements. Subjects with CHD had higher LDL-C burden at all ages tested (45, 50 and 60 years) compared with the non-CHD group (p < 0.01, also after adjusting for sex), and had higher TWA LDL-C before treatment at the Lipid Clinic (p = 0.004), but not during follow-up (p = 0.6). There were no sex differences in LDL-C burden at all ages tested, also after adjusting for CHD (p > 0.1). However, women had higher TWA LDL-C during follow-up at the Lipid Clinic (p = 0.01). Median LDL-C burden at CHD onset was 352 mM-years; numerically lower in women than in men (320 vs. 357 mM-years, respectively. p = 0.1).
Conclusion:
Elderly FH patients with CHD had higher estimated LDL-C burden compared with FH patients without CHD, due to higher burden prior to treatment, highlighting the importance of earlydetection and treatment.
More Related Videos
08:45LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring
Published on: November 17, 2018
07:29Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein
Published on: October 12, 2017
Related Concept Videos
Blood Studies for Cardiovascular System III: Serum Lipid Profile
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Cholesterol: Significance and Regulation
Considering cholesterol and...
Lipids: Dietary Sources and Requirements
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Inflammation